Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor
84%
Breast Cancer
72%
Acute Myeloid Leukemia
44%
Mammaglobin
43%
Gene Expression Profiling
40%
Bone Marrow
39%
Disseminated Tumor Cells
37%
Non-small Cell Lung Cancer (NSCLC)
31%
Gene Expression
31%
Gene Signature
31%
Breast Cancer Patients
30%
Pilocytic Astrocytoma
28%
Neoadjuvant
28%
Laser Capture Microdissection
27%
Estrogen Receptor-positive Breast Cancer
24%
Colorectal Cancer
24%
Gene Expression Profile
21%
Chemotherapy
21%
Lung Adenocarcinoma
20%
Whole Genome Sequencing
20%
Somatic mutation
19%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
19%
Quantitative PCR
18%
Oligonucleotide Array
18%
Primary Tumor
18%
ErbB2
17%
Pathological Complete Response
17%
Brain Metastases
17%
DNA Methylation (DNAm)
16%
Ki-67
16%
Estrogen Receptor
16%
Phosphoinositide 3-kinase (PI3K)
15%
Triple-negative Breast Cancer
15%
Uteroglobin
14%
Cell Population
14%
Expression Profiling
14%
Aromatase Inhibitors
14%
Gene Family
14%
Liquid Biopsy
14%
Biospecimens
14%
Randomized Clinical Trial
14%
Overexpression
14%
Human Breast Cancer
14%
Basal-like
14%
Tumor Cells
13%
Microarray Analysis
13%
Neurofibromatosis Type 1 (NF-1)
13%
High Density
13%
Neoadjuvant Chemotherapy
13%
Nonmalignant
13%
Biochemistry, Genetics and Molecular Biology
Gene Expression
89%
Genomics
71%
Gene Expression Profiling
69%
Myeloid
48%
RNA
35%
Messenger RNA
34%
Mammaglobin
33%
Estrogen Receptor
31%
Laser Capture Microdissection
22%
Genetics
21%
Cancer Cell
21%
Somatic Mutation
18%
Oligonucleotide Microarrays
18%
DNA Methylation
16%
Whole Genome Sequencing
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
15%
DNA Microarray
15%
Promoter Region
15%
Uteroglobin
14%
Gene Mutation
14%
Protein Expression
14%
Multigene Family
14%
Tissue Section
14%
Clinical Trial
14%
Proteomics
13%
DNA Sequence
13%
Methylation
13%
RNA Sequence
13%
Transcription Factors
12%
Receptor Tyrosine Kinase
12%
Carcinogenesis
11%
Trastuzumab
11%
Normal Human
11%
Gene Signature
10%
DNA Repair
10%
Germ Cell
10%
Epigenetics
10%
Kinase
10%
Phosphotransferase
10%
Exon
9%
Tumor Progression
9%
Aromatase
9%
Germline
9%
HIPK2
9%
Proto Oncogene
9%
Next Generation Sequencing
9%
Tyrosine Kinase
9%
Gene Fusion
9%
Proteogenomics
9%
Mutation Rate
9%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
46%
Metastatic Carcinoma
42%
Gene Expression
39%
Tumor
38%
Gene Expression Profiling
37%
Messenger RNA
33%
Diseases
26%
Malignant Neoplasm
24%
Hormone Therapy
21%
Biological Marker
21%
Mammaglobin
19%
Estrogen Receptor
18%
Estrogen Receptor Positive Breast Cancer
17%
Non Small Cell Lung Cancer
16%
Neoadjuvant Chemotherapy
15%
Clinical Trial
14%
Triple Negative Breast Cancer
14%
Randomized Clinical Trials
14%
Breast Tumor
14%
Primary Tumor
14%
Epidermal Growth Factor Receptor
14%
Aromatase Inhibitor
13%
Lung Cancer
12%
Hormone Receptor
12%
Arm
12%
Recurrent Disease
11%
Tumor Cell
10%
Laser Capture Microdissection
10%
Brain Metastasis
10%
Anastrozole
10%
Squamous Cell Lung Carcinoma
9%
Molecular Profiling
9%
Leukemia Cell
9%
Acute Myeloid Leukemia
9%
Phosphoinositide 3-Kinase
9%
Basal Like Breast Cancer
9%
Acute Promyelocytic Leukemia
9%
Malignant Peripheral Nerve Sheath Tumor
9%
Intraductal Carcinoma
9%
Disease Free Survival
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Proteomics
9%
Xenograft
8%
Biopsy Technique
8%
Schwann Cell
8%
Hazard Ratio
7%
Carboplatin
7%
Postmenopause
7%
Circulating Tumor Cell
7%